Alnylam Pharmaceuticals
ALNY
#586
Rank
A$54.74 B
Marketcap
$424.40
Share price
0.58%
Change (1 day)
52.19%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company